by Admin | Sep 28, 2026 | CME INDIA Case Study
CME INDIA Case Presentation by Presenting author: Dr. Kalika Prasad Dash. Discussants: Dr. N. K. Singh (Diabetes & Heart Research Centre, Dhanbad; Editor, CME India); Dr. Amit Kumar (Dermatology, Ranchi); Dr. S. K. Gupta (Delhi). CME INDIA Case Study ABSTRACT A...
by Admin | Sep 9, 2026 | CME INDIA Case Study
CME INDIA Case Presentation by Dr. Prabhat Agarwal, Professor of Medicine, Agra. CME INDIA Case Study Dapagliflozin and the Haemoglobin That Rose Too Fast — SGLT2 Inhibitor–Associated Erythrocytosis The Case A 26-year-old man with established CKD, on dapagliflozin 10...
by Admin | May 28, 2026 | CME INDIA Repository
CME INDIA Presentation by CME INDIA Team. This medical research article presents a large-scale, real-world study investigating the incidence of urogenital infections among over 15,000 type-2 diabetes patients across India. The findings reveal that patients using SGLT2...
by Admin | Jun 1, 2023 | CME INDIA Repository
CME INDIA Presentation by Dr. N.K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Based on a presentation at ADC-Bengaluru on 27th May 2023. Genitourinary infections are quite common among diabetic...
by Admin | Oct 15, 2022 | CME INDIA Repository
CME INDIA Presentation based on a case by Dr. Meena Chhabra, MD, Diabetologist, New Delhi and CME INDIA Discussion. Link to Part – I: SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients Part-2: Dr. A. K. Das, Diabetologist, Muzaffarpur: Doesn’t...
